Puntoni et al. [29] showed that VEGF is related to the clinicopathological characteristics of bladder cancer, which can reflect the development of bladder cancer patients to a certain extent, confirming that VEGF is closely related to the malignant development of bladder cancer patients, and it is expected to be used as a marker for prognostic evaluation. Here, VEGFA is linked to urinary bladder carcinoma.